Myozyme/Lumizyme Drug Sales & Forecast

Sanofi drug Myozyme/Lumizyme (alglucosidase alfa, intravenous infusion) are recombinant forms of the same human enzyme and are enzyme replacement therapies used to treat Infantile- and Late Onset Pompe disease (IOPD and LOPD), an inherited, progressive and often fatal neuromuscular disease. MNG Tracker report title “Myozyme/Lumizyme Drug Sales & Forecast” provides historical as well as estimated Myozyme/Lumizyme sales in Global, United States, Europe and Rest of the World market. This is single page report which also covered key factors for the growth/decline of the Myozyme/Lumizyme sales in Global, United States, Europe and Rest of the World market.